Table 1 Baseline Characteristics of the VBD patients
From: Recurrent risk of ischemic stroke due to Vertebrobasilar Dolichoectasia
Characteristics | Total (n = 115) | With IS Recurrence (n = 22) | Without IS Recurrence (n = 93) | P value |
|---|---|---|---|---|
Age, y; mean ± SD | 63.1 ± 10.7 | 64.9 ± 10.0 | 62.7 ± 10.8 | 0.389 |
Male (%) | 88 (76.5) | 16 (72.7) | 72 (77.4) | 0.641 |
Hypertension, n (%) | 85 (73.9) | 20 (90.9) | 65 (69.9) | 0.044 |
Diabetes mellitus, n (%) | 38 (33.0) | 12 (54.5) | 26 (28.0) | 0.017 |
IHD, n (%) | 10 (8.7) | 5 (22.7) | 5 (5.4) | 0.030 |
Hyperlipemia, n (%) | 34 (29.6) | 5 (22.7) | 29 (31.2) | 0.434 |
Smoke, n (%) | 37 (32.2) | 5 (22.7) | 32 (34.4) | 0.292 |
NIHSS, median (IQR) | 3 (1–6) | 4 (1–9) | 3 (1–6) | 0.194 |
Basilar artery geometry | ||||
≥ 5.3 mm, 90th percentile | 12 (10.4) | 8 (36.4) | 4 (4.3) | < 0.001 |
BA bifurcation, score = 3 | 7 (6.1) | 4 (18.2) | 3 (3.2) | 0.032 |
BA laterality, score ≥ 2a | 19 (16.7) | 4 (18.2) | 15 (16.3) | 1.000 |
DID | 15 (13.0) | 8 (36.4) | 7 (7.5) | 0.001 |
ICAS | 35 (30.4) | 11 (50.0) | 24 (25.8) | 0.027 |
ECAS | 15 (13.0) | 3 (13.6) | 12 (12.9) | 1.000 |
In-hospital treatment | ||||
Antiplatelet | 98 (85.2) | 18 (81.8) | 80 (86.0) | 0.869 |
Anticoagulant | 23 (20.0) | 2 (9.1) | 21 (22.6) | 0.236 |
Statins | 101 (87.8) | 20 (90.9) | 81 (87.1) | 0.897 |
IVT/thrombectomy | 7 (6.1) | 1 (4.5) | 6 (6.5) | 1.000 |